Cargando…
Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report
BACKGROUND: Sodium valproate is a commonly used anticonvulsant. It is widely recognized that valproate can cause hyperammonemia, particularly in people with underlying liver disease. Patients with urea cycle disorders are genetically predisposed to this adverse event and can develop severe hyperammo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956736/ https://www.ncbi.nlm.nih.gov/pubmed/29769109 http://dx.doi.org/10.1186/s13256-018-1666-3 |